{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:41:58Z","timestamp":1792525318920,"version":"4.5.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":6887,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutrition"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1093\/jn\/134.4.980s","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T01:43:14Z","timestamp":1516585394000},"page":"980S-988S","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":591,"title":["Hypotensive Peptides from Milk Proteins"],"prefix":"10.1016","volume":"134","author":[{"given":"Richard J.","family":"FitzGerald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/jn\/134.4.980S_bib1","unstructured":"National Heart, Lung, and Blood Institute (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Publication no. 03\u20135233. National Institutes of Health,Bethesda, MD."},{"key":"10.1093\/jn\/134.4.980S_bib2","first-page":"525","article-title":"Secondary hypertension: diagnosis and management of an adrenal adenoma","volume":"9","author":"Cohen","year":"2002","journal-title":"JCOM"},{"key":"10.1093\/jn\/134.4.980S_bib3","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/0024-3205(95)02175-8","article-title":"Role of angiotensinogen in the genetics of essential hypertension","volume":"57","author":"Hata","year":"1995","journal-title":"Life Sci"},{"key":"10.1093\/jn\/134.4.980S_bib4","first-page":"498","article-title":"Does increase in blood pressure predict increase in urinary albumin excretion rate in the first 9 years of type 1 diabetes?","volume":"12","author":"Allen","year":"2002","journal-title":"Ann. Epidemiol"},{"key":"10.1093\/jn\/134.4.980S_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0895-7061(95)00299-5","article-title":"Effect of surgical treatment on hypertension in Cushing's syndrome","volume":"9","author":"Fallo","year":"1995","journal-title":"Am. J. Hyper"},{"key":"10.1093\/jn\/134.4.980S_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0010-7824(02)00429-8","article-title":"Oral contraceptives: a risk factor for uncontrolled blood pressure among hypertensive women","volume":"67","author":"Lubianca","year":"2003","journal-title":"Contraception"},{"key":"10.1093\/jn\/134.4.980S_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1068-607X(02)00139-7","article-title":"An overview of hypertensive disorders in women","volume":"10","author":"Madankumar","year":"2003","journal-title":"Primary Care Update for Ob\/Gyns"},{"key":"10.1093\/jn\/134.4.980S_bib8","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1016\/S0895-7061(99)00107-7","article-title":"Is high blood pressure a late manifestation of the hypertension syndrome?","volume":"12","author":"Neutel","year":"1999","journal-title":"Am. J. Hyper"},{"key":"10.1093\/jn\/134.4.980S_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9149(01)02321-9","article-title":"The role of the renin-angiotensin system in the development of cardiovascular disease","volume":"89","author":"Unger","year":"2002","journal-title":"Am. J. Cardiol"},{"key":"10.1093\/jn\/134.4.980S_bib10","unstructured":"Health. Hypertension prevalence among adults, according to age, race, sex and Hispanic origin. National Centre for Health Statistics. Table 68: 210. http:\/\/www.cdc.gov\/nchs\/fastats\/hypertens.html (accessed Nov. 2002)."},{"key":"10.1093\/jn\/134.4.980S_bib11","unstructured":"Cherry, D. K. & Woodwell, D. A. (2002) National ambulatory medical care survey: 2000 summary. Advanced data from vital and health statistics. No. 328. Hyattsville, MD: National Center for Health Statistics."},{"key":"10.1093\/jn\/134.4.980S_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrd1022","article-title":"Antihypertensive treatments\u2014ALLHATs off to the golden oldie","volume":"2","author":"Frantz","year":"2003","journal-title":"Nature Rev. Drug Discov"},{"key":"10.1093\/jn\/134.4.980S_bib13","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-Z","article-title":"Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context","volume":"335","author":"Collins","year":"1990","journal-title":"The Lancet"},{"key":"10.1093\/jn\/134.4.980S_bib14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0140-6736(90)90878-9","article-title":"Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias","volume":"335","author":"MacMahon","year":"1990","journal-title":"The Lancet"},{"key":"10.1093\/jn\/134.4.980S_bib15","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0895-7061(99)00284-8","article-title":"The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial","volume":"13","author":"Conlin","year":"2000","journal-title":"Am. J. Hyperten"},{"key":"10.1093\/jn\/134.4.980S_bib16","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0002-8223(99)00414-9","article-title":"Dietary approaches to stop hypertension: a summary of study results","volume":"99","author":"Harsha","year":"1999","journal-title":"J. Am. Diet. Assoc"},{"key":"10.1093\/jn\/134.4.980S_bib17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0895-7061(03)00895-1","article-title":"How much exercise is required to reduce blood pressure in essential hypertensives: a dose-response study","volume":"16","author":"Ishikawa-Takata","year":"2003","journal-title":"Am. J. Hyperten"},{"key":"10.1093\/jn\/134.4.980S_bib18","unstructured":"World Health Organisation (2003) Diet, nutrition and the prevention of chronic diseases. WHO Technical Report Series no. 916. World Health Organisation, Geneva, Switzerland."},{"key":"10.1093\/jn\/134.4.980S_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0011-393X(01)80019-9","article-title":"Efficacy and safety of angiotensin receptor blockers: A review of Losartan in essential hypertension","volume":"62","author":"Conlin","year":"2001","journal-title":"Current Ther. Res"},{"key":"10.1093\/jn\/134.4.980S_bib20","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1021\/bi00439a001","article-title":"Angiotensin-converting enzyme: new concepts concerning its biological role","volume":"28","author":"Ehlers","year":"1989","journal-title":"Biochemistry"},{"key":"10.1093\/jn\/134.4.980S_bib21","first-page":"568","article-title":"Role of prostaglandins in the cardiovascular effects of bradykinin and angiotensin converting enzyme inhibitors","volume":"20","author":"Schr\u00f6r","year":"1992","journal-title":"J. Cardio. Pharm"},{"key":"10.1093\/jn\/134.4.980S_bib22","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/00004872-199311000-00001","article-title":"The chymase-angiotensin system in humans","volume":"11","author":"Husain","year":"1993","journal-title":"J. Hyper"},{"key":"10.1093\/jn\/134.4.980S_bib23","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(01)06584-9","article-title":"Vasopeptidase inhibitors","volume":"358","author":"Weber","year":"2001","journal-title":"The Lancet"},{"key":"10.1093\/jn\/134.4.980S_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.ph.49.030187.002213","article-title":"Functions of angiotensin in the central nervous system","volume":"49","author":"Philips","year":"1987","journal-title":"Ann. Rev. Physiol"},{"key":"10.1093\/jn\/134.4.980S_bib25","first-page":"1","article-title":"The brain renin-angiotensin system: location and physiological roles","volume":"1430","author":"McKinley","year":"2003","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"10.1093\/jn\/134.4.980S_bib26","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1006\/frne.1998.0166","article-title":"The human placental renin-angiotensin system","volume":"19","author":"Poisner","year":"1998","journal-title":"Front Neuroendocrinol"},{"key":"10.1093\/jn\/134.4.980S_bib27","first-page":"1","article-title":"Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system","volume":"1418","author":"Haznedaroglu","year":"2003","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"10.1093\/jn\/134.4.980S_bib28","first-page":"89","article-title":"Pancreatic renin-angiotensin system: a novel target for the potential traetment of pancraetic diseases?","volume":"4","author":"Leung","year":"2003","journal-title":"J. Pancreas"},{"key":"10.1093\/jn\/134.4.980S_bib29","first-page":"147","article-title":"The renin-angiotensin system","volume":"28","author":"Inagami","year":"1992","journal-title":"Essays Biochem"},{"key":"10.1093\/jn\/134.4.980S_bib30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.bi.51.070182.001435","article-title":"Enzymes of the renin-angiotensin system and their inhibitors","volume":"5","author":"Ondetti","year":"1982","journal-title":"Ann. Rev. Biochem"},{"key":"10.1093\/jn\/134.4.980S_bib31","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0008-6363(00)00163-2","article-title":"Fibrinolytic actions of ACE inhibitors: a significant plus beyond antihypertensive therapeutic effects","volume":"47","author":"Deszi","year":"2000","journal-title":"Cardio. Res"},{"key":"10.1093\/jn\/134.4.980S_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-6147(00)01994-5","article-title":"The angiotensin-converting enzyme gene family; genomics and pharmacology","volume":"23","author":"Turner","year":"2002","journal-title":"Trends Pharmcol. Sci"},{"key":"10.1093\/jn\/134.4.980S_bib33","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/01.HYP.31.6.1324","article-title":"Blood pressure independent cardiac hypertrophy induced by locally activated renin angiotensin system","volume":"31","author":"Mazzolai","year":"1998","journal-title":"Hypertension"},{"key":"10.1093\/jn\/134.4.980S_bib34","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1357-2725(02)00178-4","article-title":"Local renin-angiotensin systems: the unanswered questions","volume":"35","author":"Jan Danser","year":"2003","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"10.1093\/jn\/134.4.980S_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-2999(02)01545-5","article-title":"Interleukin-1 inhibits angiotensin II-stimulated protein kinase B pathway in renal mesangial cells via the inducible nitric oxide synthase","volume":"442","author":"R\u00f6lz","year":"2002","journal-title":"Eur. J. Pharm"},{"key":"10.1093\/jn\/134.4.980S_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/frne.1995.1002","article-title":"The angiotensin IV system: functional implications","volume":"16","author":"Wright","year":"1995","journal-title":"Front Neuroendocrinol"},{"key":"10.1093\/jn\/134.4.980S_bib37","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1357-2725(02)00273-X","article-title":"Bradykinin, angiotensin-(1\u20137), and ACE inhibitors: how do they interact?","volume":"35","author":"Tom","year":"2003","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"10.1093\/jn\/134.4.980S_bib38","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0022-3565(24)36453-5","article-title":"Different B1 kinin receptor expression and pharmacology in endothelial cells of different origins and species","volume":"280","author":"Wohlfart","year":"1997","journal-title":"J. Pharm. Exp. Ther"},{"key":"10.1093\/jn\/134.4.980S_bib39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/phrs.2000.0758","article-title":"The role of endothelins and their receptors in heart failure","volume":"43","author":"Giannessi","year":"2001","journal-title":"Pharm. Res"},{"key":"10.1093\/jn\/134.4.980S_bib40","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/01.HYP.33.2.746","article-title":"Kidney aminopeptidase A and hypertension, part II: effects of angiotensin II","volume":"33","author":"Song","year":"1999","journal-title":"Hypertension"},{"key":"10.1093\/jn\/134.4.980S_bib41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0895-7061(95)00349-5","article-title":"Chymase dependent angiotensin II forming system in humans","volume":"9","author":"Urata","year":"1996","journal-title":"Am. J. Hyper"},{"key":"10.1093\/jn\/134.4.980S_bib42","first-page":"374","article-title":"A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin","volume":"214","author":"Yang","year":"1970","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1093\/jn\/134.4.980S_bib43","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/01.HYP.30.4.830","article-title":"Reversal of endothelin-I release by stimulation of endothelial \u03b12-adrenoreceptor contributes to cerebral vasorelaxation","volume":"30","author":"Thorin","year":"1997","journal-title":"Hypertension"},{"key":"10.1093\/jn\/134.4.980S_bib44","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/hy0901s1.095011","article-title":"Angiotensin-I-converting enzyme modulates neutral endopeptidase activity in the rat","volume":"38","author":"Oliveri","year":"2001","journal-title":"Hypertension"},{"key":"10.1093\/jn\/134.4.980S_bib45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/01.HYP.35.1.329","article-title":"Obesity is associated with tissue specific activation of renal angiotensin converting enzyme in vivo: evidence for a regulatory role of endothelin","volume":"35","author":"Barton","year":"2000","journal-title":"Hypertension"},{"key":"10.1093\/jn\/134.4.980S_bib46","first-page":"1","article-title":"Biochemical and functional characterisation of endothelin peptides with special reference to vascular effects","volume":"602","author":"Hemsen","year":"1991","journal-title":"Acta Physiol. Scand. Suppl"},{"key":"10.1093\/jn\/134.4.980S_bib47","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1161\/01.HYP.30.6.1591","article-title":"Endothelin converting enzyme \u2013 1 gene expression in the kidney of spontaneously hypertensive rats","volume":"30","author":"Disashi","year":"1997","journal-title":"Hypertension"},{"key":"10.1093\/jn\/134.4.980S_bib48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/eurheartj\/16.suppl_K.4","article-title":"Maintenance of vascular integrity: role of nitric oxide and other bradykinin mediators","volume":"1","author":"Cosentino","year":"1995","journal-title":"Eur. Heart J"},{"key":"10.1093\/jn\/134.4.980S_bib49","doi-asserted-by":"crossref","first-page":"26428","DOI":"10.1016\/S0021-9258(19)74332-4","article-title":"Proteolytic release of human angiotensin converting enzyme: localization of the cleavage site","volume":"268","author":"Beldent","year":"1993","journal-title":"J. Biol. Chem"},{"key":"10.1093\/jn\/134.4.980S_bib50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1050-1738(02)00233-5","article-title":"The role of ACE2 in cardiovascular physiology","volume":"13","author":"Oudit","year":"2003","journal-title":"Trend. Cardiovasc. Med"},{"key":"10.1093\/jn\/134.4.980S_bib51","first-page":"G781","article-title":"Role of rat intestinal brush border membrane angiotensin converting enzyme in dietary protein digestion","volume":"253","author":"Yoshioka","year":"1987","journal-title":"Am. J. Physiol"},{"key":"10.1093\/jn\/134.4.980S_bib52","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0006-2952(71)90292-9","article-title":"Spectrophotometric assay and properties of the angiotensin converting enzyme of rabbit lung","volume":"20","author":"Cushman","year":"1971","journal-title":"Biochem. Pharm"},{"key":"10.1093\/jn\/134.4.980S_bib53","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0731-7085(98)00122-8","article-title":"Liquid chromatographic determination of hippuric acid for the evaluation of ethacrynic acid as angiotensin converting enzyme inhibitor","volume":"19","author":"Mehanna","year":"1999","journal-title":"J. Pharm. Biomed. Anal"},{"key":"10.1093\/jn\/134.4.980S_bib54","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/0003-2697(79)90769-3","article-title":"A continuous spectrophotometric assay for the angiotensin converting enzyme","volume":"95","author":"Holmquist","year":"1979","journal-title":"Anal. Biochem"},{"key":"10.1093\/jn\/134.4.980S_bib55","doi-asserted-by":"crossref","unstructured":"Murray, B. A., Walsh, D. J. & FitzGerald, R. J. (2004) Modification of the furanacryloyl-L-phenylalanylglycylglycine assay for determination of angiotensin-I-converting enzyme inhibitory activity. J. Biochem. Biophys. Meth. (in press).","DOI":"10.1016\/j.jbbm.2003.12.009"},{"key":"10.1093\/jn\/134.4.980S_bib56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-2006-960050","article-title":"A new method for the in vitro screening of inhibitors of angiotensin converting enzyme (ACE), using the chromophore- and fluorophore-labelled substrate, dansyltriglycine","volume":"57","author":"Elbl","year":"1994","journal-title":"Planta. Med"},{"key":"10.1093\/jn\/134.4.980S_bib57","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1021\/bi00815a005","article-title":"Isolation of bradykinin-potentiating peptides from Bothrops jaraca venom","volume":"9","author":"Ferriera","year":"1970","journal-title":"Biochem"},{"key":"10.1093\/jn\/134.4.980S_bib58","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1126\/science.191908","article-title":"Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents","volume":"196","author":"Ondetti","year":"1977","journal-title":"Science"},{"key":"10.1093\/jn\/134.4.980S_bib59","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/med.2610050405","article-title":"Recent developments in the design of angiotensin-converting enzyme inhibitors","volume":"5","author":"Wyvratt","year":"1985","journal-title":"Med. Res. Rev"},{"key":"10.1093\/jn\/134.4.980S_bib60","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.CIR.97.14.1411","article-title":"Angiotensin-converting enzyme inhibitors","volume":"97","author":"Brown","year":"1998","journal-title":"Circulation"},{"key":"10.1093\/jn\/134.4.980S_bib61","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0002-9149(83)80200-8","article-title":"Negative effects of diuretic drugs on metabolic risk factors for coronary heart disease","volume":"51","author":"Ames","year":"1983","journal-title":"Am. J. Cardiol"},{"key":"10.1093\/jn\/134.4.980S_bib62","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archinte.1985.00360080206033","article-title":"Cough associated with the use of captopril","volume":"145","author":"Seseko","year":"1985","journal-title":"Arch. Intern. Med"},{"key":"10.1093\/jn\/134.4.980S_bib63","doi-asserted-by":"crossref","first-page":"24E","DOI":"10.1016\/0002-9149(87)90538-8","article-title":"Effects of antihypertensive drugs on plasma lipid","volume":"60","author":"Nakamura","year":"1987","journal-title":"Am. J. Cardiol"},{"key":"10.1093\/jn\/134.4.980S_bib64","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2165\/00002018-200124080-00004","article-title":"Drug-induced angioedema without urticaria","volume":"24","author":"Agostoni","year":"2001","journal-title":"Drug Saf"},{"key":"10.1093\/jn\/134.4.980S_bib65","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0924-2244(93)90033-7","article-title":"Angiotensin-converting enzyme inhibitors derived from food proteins","volume":"4","author":"Ariyoshi","year":"1993","journal-title":"Trends Food Sci. Technol"},{"key":"10.1093\/jn\/134.4.980S_bib66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/S0007114500002221","article-title":"Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme","volume":"84","author":"FitzGerald","year":"2000","journal-title":"Br. J. Nutr"},{"key":"10.1093\/jn\/134.4.980S_bib67","doi-asserted-by":"crossref","unstructured":"Walsh, D. J. & FitzGerald, R. J. (2004) The functional value of dairy proteins. In: Proteins in Food Processing (Yada, R., ed.), Woodhead Publishing Limited, Cambridge, UK (in press).","DOI":"10.1201\/9781439823309.ch23"},{"key":"10.1093\/jn\/134.4.980S_bib68","first-page":"1581","article-title":"Studies on the active site and antihypertensive activity of angiotensin I-converting enzyme inhibitors derived from casein","volume":"51","author":"Maruyama","year":"1987","journal-title":"Agric. Biol. Chem"},{"key":"10.1093\/jn\/134.4.980S_bib69","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0014-5793(02)03576-7","article-title":"Angiotensin-I-converting enzyme inhibitory peptides from tryptic hydrolysate of bovine \u03b1s2-casein","volume":"531","author":"Tauzin","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1093\/jn\/134.4.980S_bib70","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3168\/jds.S0022-0302(95)76689-9","article-title":"Purification and characterization of angiotensin I-converting enzyme inhibitors from a sour milk","volume":"78","author":"Nakamura","year":"1995","journal-title":"J. Dairy Sci"},{"key":"10.1093\/jn\/134.4.980S_bib71","unstructured":"Schlothauer, R-C., Schollum, L. M., Singh, A. M. & Reid, J. R. (1999) Bioactive whey protein hydrolysate. World Patent WO 99\/65326."},{"key":"10.1093\/jn\/134.4.980S_bib72","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1017\/S0022029999003982","article-title":"Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterisation of active peptides","volume":"67","author":"Pihlanto-Lepp\u00e4l\u00e4","year":"2000","journal-title":"J. Dairy Res"},{"key":"10.1093\/jn\/134.4.980S_bib73","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-5793(96)01503-7","article-title":"Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine \u03b2-lactoglobulin","volume":"402","author":"Mullally","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1093\/jn\/134.4.980S_bib74","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1271\/kagakutoseibutsu1962.29.454","article-title":"Bioactive peptides derived from food proteins","volume":"29","author":"Chiba","year":"1991","journal-title":"Kagaku and Seibutsu (in Japanese)"},{"key":"10.1093\/jn\/134.4.980S_bib75","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0021-9258(19)86187-2","article-title":"Binding of peptide substrates and inhibitors of angiotensin-converting-enyzme","volume":"255","author":"Cheung","year":"1980","journal-title":"J. Biol. Chem"},{"key":"10.1093\/jn\/134.4.980S_bib76","unstructured":"Meisel, H. (1993) Casokinins as inhibitors of angiotensin-I-converting enzyme. In: New Perspectives in Infant Nutrition (Sawatski, G. & Renner, B., eds.), pp. 153\u2013159. Thieme, Stuttgart, New York."},{"key":"10.1093\/jn\/134.4.980S_bib77","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.3168\/jds.S0022-0302(98)75878-3","article-title":"Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion","volume":"81","author":"Abubakar","year":"1998","journal-title":"J. Dairy Sci"},{"key":"10.1093\/jn\/134.4.980S_bib78","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/A:1002063805780","article-title":"Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties","volume":"76","author":"Meisel","year":"1999","journal-title":"Ant. van Leeuwen"},{"key":"10.1093\/jn\/134.4.980S_bib79","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1128\/AEM.66.9.3898-3904.2000","article-title":"Production of angiotensin-I-converting enzyme inhibitory peptides in fermented milks started by Lactobacillus delbruekii subsp. bulgaricus SS1 and Lactococcus lactis subsp cremoris FT4","volume":"66","author":"Gobbetti","year":"2000","journal-title":"Appl. Envir. Microbiol"},{"key":"10.1093\/jn\/134.4.980S_bib80","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3168\/jds.S0022-0302(96)76487-1","article-title":"Identification of antihypertensive peptides from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790","volume":"73","author":"Maeno","year":"1996","journal-title":"J. Dairy Sci"},{"key":"10.1093\/jn\/134.4.980S_bib81","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3168\/jds.S0022-0302(99)75364-6","article-title":"Purification and characterisation of an antihypertensive peptide from yoghurt-like product fermented by Lactobacillus helveticus CPN4","volume":"82","author":"Yamamoto","year":"1999","journal-title":"J. Dairy Sci"},{"key":"10.1093\/jn\/134.4.980S_bib82","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0958-6946(98)00048-X","article-title":"Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins","volume":"8","author":"Pihlanto-Lepp\u00e4l\u00e4","year":"1998","journal-title":"Int. Dairy J"},{"key":"10.1093\/jn\/134.4.980S_bib83","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1128\/AEM.68.7.3566-3569.2002","article-title":"Cardiovascular effects of fermented milk containing angiotensin-converting enzyme inhibitors evaluated in permanently cathereterized spontaneously hypertensive rats","volume":"68","author":"Fuglsang","year":"2002","journal-title":"Appl. Envir. Microbiol"},{"key":"10.1093\/jn\/134.4.980S_bib84","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1017\/S002202990100526X","article-title":"Effect of long-term intake of milk products on blood pressure in hypertensive rats","volume":"69","author":"Sipola","year":"2002","journal-title":"J. Dairy Res"},{"key":"10.1093\/jn\/134.4.980S_bib85","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0958-6946(02)00125-5","article-title":"Antihypertensive activity of casein-enriched milk fermented by Lactobacillus helveticus","volume":"12","author":"Leclerc","year":"2002","journal-title":"Int. Dairy J"},{"key":"10.1093\/jn\/134.4.980S_bib86","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1017\/S0022029900030673","article-title":"Characterisation of the 12% trichloroacetic acid insoluble oligopeptides of Parmigiano-Reggiano cheese","volume":"59","author":"Addeo","year":"1992","journal-title":"J. Dairy Res"},{"key":"10.1093\/jn\/134.4.980S_bib87","first-page":"307","article-title":"ACE-inhibitory activities in milk products","volume":"52","author":"Meisel","year":"1997","journal-title":"Milchwiss"},{"key":"10.1093\/jn\/134.4.980S_bib88","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.3168\/jds.S0022-0302(00)75013-2","article-title":"Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese","volume":"83","author":"Saito","year":"2000","journal-title":"J. Dairy Sci"},{"key":"10.1093\/jn\/134.4.980S_bib89","first-page":"373","article-title":"Immunoreactivity and inhibition of angiotensin I converting enzyme and lactococcal oligopeptidase by peptides from cheese","volume":"13","author":"Stepaniak","year":"2001","journal-title":"Ital. J. Food Sci"},{"key":"10.1093\/jn\/134.4.980S_bib90","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0958-6946(01)00079-6","article-title":"A new type of ripened, low-fat cheese with bioactive properties","volume":"11","author":"Ryh\u00e4nen","year":"2001","journal-title":"Int. Dairy J"},{"key":"10.1093\/jn\/134.4.980S_bib91","doi-asserted-by":"crossref","unstructured":"FitzGerald, R. J. & Meisel, H. (2003) Milk protein hydrolysates and bioactive peptides. In: Advanced Dairy Chemistry, Volume 1, 3rd Edition, Part B (Fox, P. F. & McSweeney, P.L.H., eds.), pp 675\u2013698. Kluwer Academic\/Plenum Publishers, New York\/Boston\/Dordrecht\/London\/Moscow.","DOI":"10.1007\/978-1-4419-8602-3_20"},{"key":"10.1093\/jn\/134.4.980S_bib92","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/psc.371","article-title":"Intestinal transport of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg through a Caco-2 Bbe monolayer","volume":"8","author":"Vermeirssen","year":"2002","journal-title":"J. Pep. Sci"},{"key":"10.1093\/jn\/134.4.980S_bib93","first-page":"367","article-title":"Antihypertensive effect of tryptic hydrolysate of milk casein in spontaneously hypertensive rats","volume":"96C","author":"Karaki","year":"1990","journal-title":"Comp. Biochem. Physiol"},{"key":"10.1093\/jn\/134.4.980S_bib94","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0024-3205(00)00471-9","article-title":"\u03b1-Lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats","volume":"66","author":"Nurminen","year":"2000","journal-title":"Life Sci"},{"key":"10.1093\/jn\/134.4.980S_bib95","first-page":"259","article-title":"Synthetic peptides corresponding to \u03b1-lactalbumin and \u03b2-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity","volume":"377","author":"Mullally","year":"1996","journal-title":"Biol. Chem. Hoppe-Seyler"},{"key":"10.1093\/jn\/134.4.980S_bib96","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4327\/jsnfs.45.513","article-title":"Antihypertensive effects of tryptic hydrolysate of casein on normotensive and hypertensive volunteers (in Japanese)","volume":"45","author":"Sekiya","year":"1992","journal-title":"J. Jap. Soc. Nutr. Food Sci"},{"key":"10.1093\/jn\/134.4.980S_bib97","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/ajcn\/64.5.767","article-title":"A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects","volume":"64","author":"Hata","year":"1996","journal-title":"Amer. J. Clin. Nutr"},{"key":"10.1093\/jn\/134.4.980S_bib98","first-page":"124","article-title":"The effect of a Lactobacillus helveticus LBK-16 H fermented milk on hypertension\u2014a pilot study on humans","volume":"57","author":"Seppo","year":"2002","journal-title":"Milchwissen"},{"key":"10.1093\/jn\/134.4.980S_bib99","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ajcn\/77.2.326","article-title":"A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects","volume":"77","author":"Seppo","year":"2003","journal-title":"Am. J. Clin. Nutr"},{"key":"10.1093\/jn\/134.4.980S_bib100","unstructured":"Nimmagudda, R. (2002) New bioactive peptides for the nutritional industry. Oral presentation at: SupplySide West Trade Show and Conference, Las Vegas, NV, December 4th to 6th."},{"key":"10.1093\/jn\/134.4.980S_bib101","first-page":"68","article-title":"The antihypertensive effects of a hydrolysed whey protein isolate supplement (BioZate\u00ae 1)","volume":"16","author":"Pins","year":"2002","journal-title":"Cardiovasc. Drugs Ther"},{"key":"10.1093\/jn\/134.4.980S_bib102","first-page":"A1110","article-title":"The antihypertensive effects of a hydrolysed whey protein isolate supplement (BioZate\u00ae 1): A pilot study","volume":"17","author":"Pins","year":"2003","journal-title":"FASEB J"}],"container-title":["The Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316623027463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316623027463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/jn\/article-pdf\/134\/4\/980S\/24006965\/z4w0040400s980.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T19:19:37Z","timestamp":1751224777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022316623027463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0022316623027463"],"URL":"https:\/\/doi.org\/10.1093\/jn\/134.4.980s","relation":{},"ISSN":["0022-3166"],"issn-type":[{"value":"0022-3166","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypotensive Peptides from Milk Proteins","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/jn\/134.4.980S","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}